Trial Profile
Characterization and Treatment of CNS Abnormalities in Premutation Carriers: A Double-Blind Placebo-Controlled Trial of Memantine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2017
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Fragile X tremor ataxia syndrome
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 03 Nov 2015 New trial record